Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP410395.RAbpAKB3ebDpmCNVVykUoO_Ru6MA_-Bv1I7ykPs0NaNzw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP410395.RAbpAKB3ebDpmCNVVykUoO_Ru6MA_-Bv1I7ykPs0NaNzw130_assertion type Assertion NP410395.RAbpAKB3ebDpmCNVVykUoO_Ru6MA_-Bv1I7ykPs0NaNzw130_head.
- NP410395.RAbpAKB3ebDpmCNVVykUoO_Ru6MA_-Bv1I7ykPs0NaNzw130_assertion description "[The methylation frequencies of CHFR, DAP-kinase, E-cadherin, hMLH1, p16, RASSF1A, and RUNX3 genes were 16.2%, 21.4%, 27.0%, 8.1%, 24.3%, 27.0%, and 56.8%, respectively, in primary biliary tract carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410395.RAbpAKB3ebDpmCNVVykUoO_Ru6MA_-Bv1I7ykPs0NaNzw130_provenance.
- NP410395.RAbpAKB3ebDpmCNVVykUoO_Ru6MA_-Bv1I7ykPs0NaNzw130_assertion evidence source_evidence_literature NP410395.RAbpAKB3ebDpmCNVVykUoO_Ru6MA_-Bv1I7ykPs0NaNzw130_provenance.
- NP410395.RAbpAKB3ebDpmCNVVykUoO_Ru6MA_-Bv1I7ykPs0NaNzw130_assertion SIO_000772 15471559 NP410395.RAbpAKB3ebDpmCNVVykUoO_Ru6MA_-Bv1I7ykPs0NaNzw130_provenance.
- NP410395.RAbpAKB3ebDpmCNVVykUoO_Ru6MA_-Bv1I7ykPs0NaNzw130_assertion wasDerivedFrom befree-20140225 NP410395.RAbpAKB3ebDpmCNVVykUoO_Ru6MA_-Bv1I7ykPs0NaNzw130_provenance.
- NP410395.RAbpAKB3ebDpmCNVVykUoO_Ru6MA_-Bv1I7ykPs0NaNzw130_assertion wasGeneratedBy ECO_0000203 NP410395.RAbpAKB3ebDpmCNVVykUoO_Ru6MA_-Bv1I7ykPs0NaNzw130_provenance.